244 related articles for article (PubMed ID: 10226856)
1. Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium.
McVey MJ; Smits GJ; Cox BF; Kitzen JM; Clark KL; Perrone MH
J Cardiovasc Pharmacol; 1999 May; 33(5):703-10. PubMed ID: 10226856
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective effects of the novel adenosine A1/A2 receptor agonist AMP 579 in a porcine model of myocardial infarction.
Smits GJ; McVey M; Cox BF; Perrone MH; Clark KL
J Pharmacol Exp Ther; 1998 Aug; 286(2):611-8. PubMed ID: 9694911
[TBL] [Abstract][Full Text] [Related]
3. Amp 579 reduces contracture and limits infarction in rabbit heart by activating adenosine A2 receptors.
Xu Z; Downey JM; Cohen MV
J Cardiovasc Pharmacol; 2001 Sep; 38(3):474-81. PubMed ID: 11486252
[TBL] [Abstract][Full Text] [Related]
4. The effect of body temperature on myocardial protection conferred by ischaemic preconditioning or the selective adenosine A1 receptor agonist GR79236, in an anaesthetized rabbit model of myocardial ischaemia and reperfusion.
Sheldrick A; Gray KM; Drew GM; Louttit JB
Br J Pharmacol; 1999 Sep; 128(2):385-95. PubMed ID: 10510449
[TBL] [Abstract][Full Text] [Related]
5. Intravenous AMP 579, a novel adenosine A(1)/A(2a) receptor agonist, induces a delayed protection against myocardial infarction in minipig.
Meng H; McVey M; Perrone M; Clark KL
Eur J Pharmacol; 2000 Jan; 387(1):101-5. PubMed ID: 10633167
[TBL] [Abstract][Full Text] [Related]
6. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.
Reid EA; Kristo G; Yoshimura Y; Ballard-Croft C; Keith BJ; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2253-9. PubMed ID: 15653762
[TBL] [Abstract][Full Text] [Related]
7. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning.
Matsuda M; Catena TG; Vander Heide RS; Jennings RB; Reimer KA
Cardiovasc Res; 1993 Apr; 27(4):585-92. PubMed ID: 8324790
[TBL] [Abstract][Full Text] [Related]
8. A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs.
Auchampach JA; Ge ZD; Wan TC; Moore J; Gross GJ
Am J Physiol Heart Circ Physiol; 2003 Aug; 285(2):H607-13. PubMed ID: 12689858
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A1/A2a receptor agonist AMP-579 induces acute and delayed preconditioning against in vivo myocardial stunning.
Kristo G; Yoshimura Y; Keith BJ; Stevens RM; Jahania SA; Mentzer RM; Lasley RD
Am J Physiol Heart Circ Physiol; 2004 Dec; 287(6):H2746-53. PubMed ID: 15271662
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs.
Vander Heide RS; Reimer KA
Cardiovasc Res; 1996 May; 31(5):711-8. PubMed ID: 8763400
[TBL] [Abstract][Full Text] [Related]
11. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
12. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia.
Toombs CF; McGee S; Johnston WE; Vinten-Johansen J
Circulation; 1992 Sep; 86(3):986-94. PubMed ID: 1516210
[TBL] [Abstract][Full Text] [Related]
13. An adenosine agonist and preconditioning shift the distribution of myocardial blood flow in conscious pigs.
Huang CH; Kim SJ; Ghaleh B; Kudej RK; Shen YT; Bishop SP; Vatner SF
Am J Physiol; 1999 Feb; 276(2):H368-75. PubMed ID: 9950835
[TBL] [Abstract][Full Text] [Related]
14. Influence of the angiotensin II AT1 receptor antagonist irbesartan on ischemia/reperfusion injury in the dog heart.
Preckel B; Schlack W; Gonzàlez M; Obal D; Barthel H; Thämer V
Basic Res Cardiol; 2000 Oct; 95(5):404-12. PubMed ID: 11099168
[TBL] [Abstract][Full Text] [Related]
15. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the heart.
Neely CF; DiPierro FV; Kong M; Greelish JP; Gardner TJ
Circulation; 1996 Nov; 94(9 Suppl):II376-80. PubMed ID: 8901778
[TBL] [Abstract][Full Text] [Related]
16. Does preconditioning protect the coronary vasculature from subsequent ischemia/reperfusion injury?
Bauer B; Simkhovich BZ; Kloner RA; Przyklenk K
Circulation; 1993 Aug; 88(2):659-72. PubMed ID: 8339428
[TBL] [Abstract][Full Text] [Related]
17. The effects of the endothelin ETA receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion.
McMurdo L; Thiemermann C; Vane JR
Br J Pharmacol; 1994 May; 112(1):75-80. PubMed ID: 8032665
[TBL] [Abstract][Full Text] [Related]
18. Glibenclamide antagonizes adenosine A1 receptor-mediated cardioprotection in stunned canine myocardium.
Yao Z; Gross GJ
Circulation; 1993 Jul; 88(1):235-44. PubMed ID: 8319338
[TBL] [Abstract][Full Text] [Related]
19. Adenosine A1 receptor blockade does not abolish the cardioprotective effects of the adenosine triphosphate-sensitive potassium channel opener bimakalim.
Gross GJ; Mei DA; Sleph PG; Grover GJ
J Pharmacol Exp Ther; 1997 Feb; 280(2):533-40. PubMed ID: 9023261
[TBL] [Abstract][Full Text] [Related]
20. An adenosine A1 receptor agonist, R(-)-N-(2-phenylisopropyl)-adenosine (PIA), but not adenosine itself, acts as a therapeutic preconditioning-mimetic agent in rabbits.
Hale SL; Bellows SD; Hammerman H; Kloner RA
Cardiovasc Res; 1993 Dec; 27(12):2140-5. PubMed ID: 8313421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
